Friday, October 2, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

GLP-1semaglutideglp-1dermatologyeadv

French study links GLP-1 use to fourfold rise in nail detachment

A companion study of the same 1,904 patients found 50% of GLP-1 users reported unusual hair loss versus 34% of non-users, often with scalp redness and itching.

MH
By Maren Holt · Senior Reporter, GLP-1
Oct 1 06:10 ETSource: Drugs.com

The wire

  1. 01Among 1,904 people with type 2 diabetes and/or obesity, 575 GLP-1 users reported nail disorders at 66% versus 53% of non-users, with nail discoloration at 46% versus 17%, presented at EADV in Vienna.
  2. 02Researchers said higher risks persisted after accounting for weight loss and prior nail problems, leaving users two to three times more prone to detachment or discoloration.
  3. 03The investigators say the cross-sectional design cannot prove cause and effect; a prospective trial tracking hair, scalp and nails from treatment start is planned.

From the source

Odds Of Losing Your Nails, Hair Rise With GLP-1 Use

THURSDAY, Oct. 1, 2026 — You're up to four times more prone to losing a nail after you start a GLP-1 medicine than before, a new study suggests. Risk for nail discoloration also rises when taking GLP-1s, according to a French study. The...

Read at drugs.com
PeptiPrescribed peptides from $99/moSee all →